These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33661862)

  • 1. Estimated SARS-CoV-2 Seroprevalence Among Persons Aged <18 Years - Mississippi, May-September 2020.
    Hobbs CV; Drobeniuc J; Kittle T; Williams J; Byers P; Satheshkumar PS; Inagaki K; Stephenson M; Kim SS; Patel MM; Flannery B;
    MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(9):312-315. PubMed ID: 33661862
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
    Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
    Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The seroprevalence of SARS-CoV-2 in a rural southwest community.
    Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
    J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.
    Shakiba M; Nazemipour M; Salari A; Mehrabian F; Nazari SSH; Rezvani SM; Ghasempour Z; Heidarzadeh A; Mansournia MA
    Emerg Infect Dis; 2021 Feb; 27(2):636-638. PubMed ID: 33349310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients.
    Del Zompo F; De Maio F; Santopaolo F; Ricci R; Gasbarrini A; Pompili M; Ponziani FR
    Dig Liver Dis; 2021 May; 53(5):541-544. PubMed ID: 33707148
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of SARS-CoV-2 antibodies in health care personnel of two acute care hospitals in Linz, Austria.
    Egger M; Bundschuh C; Wiesinger K; Bräutigam E; Berger T; Clodi M; Dieplinger B
    Clin Chem Lab Med; 2021 May; 59(6):e231-e234. PubMed ID: 33554543
    [No Abstract]   [Full Text] [Related]  

  • 7. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
    Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP;
    Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe acute respiratory syndrome coronavirus 2 antibodies in pregnant women admitted to labor and delivery units.
    Haizler-Cohen L; Davidov A; Blitz MJ; Fruhman G
    Am J Obstet Gynecol; 2021 Jan; 224(1):112-114. PubMed ID: 32971014
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.
    Bajema KL; Wiegand RE; Cuffe K; Patel SV; Iachan R; Lim T; Lee A; Moyse D; Havers FP; Harding L; Fry AM; Hall AJ; Martin K; Biel M; Deng Y; Meyer WA; Mathur M; Kyle T; Gundlapalli AV; Thornburg NJ; Petersen LR; Edens C
    JAMA Intern Med; 2021 Apr; 181(4):450-460. PubMed ID: 33231628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.
    Yoshiyama T; Saito Y; Masuda K; Nakanishi Y; Kido Y; Uchimura K; Mitarai S; Suzuki T; Nakagama Y; Kubota H; Satomi M; Uchikoba S; Ohnishi M; Wakita T; Kato S; Kato K
    Emerg Infect Dis; 2021 Feb; 27(2):628-631. PubMed ID: 33496235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of Case-Based Seroprevalence of SARS-CoV-2 Antibodies in Maricopa County, Arizona.
    Jehn M; Pandit U; Sabin S; Tompkins C; White J; Kaleta E; Dale AP; Ross HM; Mac McCullough J; Pepin S; Kenny K; Sanborn H; Heywood N; Schnall AH; Lant T; Sunenshine R
    Am J Public Health; 2022 Jan; 112(1):38-42. PubMed ID: 34936397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak.
    Stringhini S; Zaballa ME; Perez-Saez J; Pullen N; de Mestral C; Picazio A; Pennacchio F; Wisniak A; Richard A; Baysson H; Loizeau A; Balavoine JF; Trono D; Pittet D; Posfay-Barbe K; Flahault A; Chappuis F; Kherad O; Vuilleumier N; Kaiser L; Azman AS; Guessous I;
    Lancet Infect Dis; 2021 May; 21(5):600-601. PubMed ID: 33539733
    [No Abstract]   [Full Text] [Related]  

  • 13. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the Netherlands.
    McDonald SA; Miura F; Vos ERA; van Boven M; de Melker HE; van der Klis FRM; van Binnendijk RS; den Hartog G; Wallinga J
    Eur J Epidemiol; 2021 Jul; 36(7):735-739. PubMed ID: 34114187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal SARS-CoV-2 seroconversion and functional heterogeneity in a pediatric dialysis unit.
    Canas JJ; Starr MC; Hooks J; Arregui S; Wilson AC; Carroll AE; Saxena V; Amanat F; Krammer F; Fill J; Schade A; Chambers A; Schneider J; Schwaderer AL; Hains DS
    Kidney Int; 2021 Feb; 99(2):484-486. PubMed ID: 33509357
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020.
    Kar SS; Sarkar S; Murali S; Dhodapkar R; Joseph NM; Aggarwal R
    Emerg Infect Dis; 2021 Feb; 27(2):666-669. PubMed ID: 33496645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased?
    Takahashi S; Greenhouse B; Rodríguez-Barraquer I
    J Infect Dis; 2020 Nov; 222(11):1772-1775. PubMed ID: 32856712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021.
    Uyoga S; Adetifa IMO; Otiende M; Yegon C; Agweyu A; Warimwe GM; Scott JAG
    JAMA; 2021 Oct; 326(14):1436-1438. PubMed ID: 34473191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel.
    Reicher S; Ratzon R; Ben-Sahar S; Hermoni-Alon S; Mossinson D; Shenhar Y; Friger M; Lustig Y; Alroy-Preis S; Anis E; Sadetzki S; Kaliner E
    Eur J Epidemiol; 2021 Jul; 36(7):727-734. PubMed ID: 33884542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of SARS-CoV-2 antibodies in children: a prospective multicentre cohort study.
    Waterfield T; Watson C; Moore R; Ferris K; Tonry C; Watt A; McGinn C; Foster S; Evans J; Lyttle MD; Ahmad S; Ladhani S; Corr M; McFetridge L; Mitchell H; Brown K; Amirthalingam G; Maney JA; Christie S
    Arch Dis Child; 2021 Jul; 106(7):680-686. PubMed ID: 33172887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.